Pathology Lab Services

PCR (Polymerase Chain Reaction) is a molecular technique used to amplify and detect specific DNA or RNA sequences. - **Qualitative PCR** determines the presence or absence of a particular genetic material, making it useful for diagnosing infections, such as viral or bacterial diseases. - **Quantitative PCR (qPCR)** not only detects the presence of the target sequence but also measures its quantity, providing insights into viral load, gene expression, or the severity of an infection. Both qualitative and quantitative PCR are powerful tools in research and clinical diagnostics, allowing for sensitive and specific detection of pathogens or genetic conditions.

PCR C (Polymerase Chain Reaction for Cytomegalovirus) is used specifically to detect and quantify cytomegalovirus (CMV) in blood or other body fluids. - **Qualitative PCR C** identifies whether CMV is present, helping diagnose infections, especially in immunocompromised patients. - **Quantitative PCR C** measures the viral load, providing valuable information about the severity of the infection and guiding treatment decisions. Both qualitative and quantitative PCR C are crucial for managing CMV-related diseases, particularly in transplant recipients and those with weakened immune systems.

CMV PCR (Cytomegalovirus Polymerase Chain Reaction) is a diagnostic test used to detect and measure the presence of CMV in the body. - **Qualitative CMV PCR** determines whether the virus is present or absent, making it useful for diagnosing active infections, especially in immunocompromised patients. - **Quantitative CMV PCR** measures the viral load, providing information on the severity of the infection and helping guide treatment decisions. Both tests are essential for managing CMV infections, particularly in individuals such as organ transplant recipients and those with weakened immune systems, where early detection and monitoring are crucial.

HDV PCR (Hepatitis D Virus Polymerase Chain Reaction) is a diagnostic test used to detect and measure the presence of hepatitis D virus. - **Qualitative HDV PCR** determines whether the virus is present, helping diagnose active hepatitis D infection, particularly in patients co-infected with hepatitis B. - **Quantitative HDV PCR** measures the viral load, providing insights into the severity of the infection and helping guide treatment decisions. Both tests are important for monitoring hepatitis D, especially in individuals at risk of liver complications, as early detection and management can improve outcomes.

Typhoid PCR (Polymerase Chain Reaction) qualitative testing is used to detect the presence of Salmonella enterica serotype Typhi, the bacteria responsible for typhoid fever. This sensitive and specific test identifies the genetic material of the bacteria in blood or other samples. A positive result confirms an active infection, allowing for timely diagnosis and treatment. PCR is particularly useful in cases where traditional cultures may be negative or delayed, ensuring rapid intervention to prevent complications associated with typhoid fever.

HBV genotyping is a laboratory test that determines the specific strain or genotype of the hepatitis B virus (HBV) infecting an individual. There are several HBV genotypes (A to J), and the genotype can influence the disease's progression, response to antiviral treatments, and potential for liver complications. Identifying the HBV genotype helps healthcare providers tailor treatment plans and predict outcomes, making it an important aspect of managing chronic hepatitis B infection. This information is particularly valuable in guiding therapy decisions and monitoring the effectiveness of treatment over time.

HCV genotyping is a test that identifies the specific strain or genotype of the hepatitis C virus (HCV) in an individual. There are several genotypes (1 to 6), each with different subtypes and variations. Knowing the HCV genotype is crucial for determining the most effective treatment regimen and predicting the likelihood of a sustained virologic response (SVR). It also helps assess the duration of therapy needed, making HCV genotyping an essential component of managing hepatitis C infection and guiding personalized treatment strategies.

HPV PCR typing is a molecular test used to detect and identify specific types of human papillomavirus (HPV) in a sample, typically from cervical tissue or vaginal swabs. This test can distinguish between high-risk and low-risk HPV types. High-risk HPV types are associated with cervical cancer and other anogenital cancers, while low-risk types are linked to benign conditions like warts. HPV PCR typing provides valuable information for assessing the risk of cancer, guiding screening protocols, and determining the need for further diagnostic procedures. It is a key tool in the prevention and management of HPV-related diseases.

The BRAF V600 mutation test detects a specific genetic alteration in the BRAF gene, commonly associated with various cancers, particularly melanoma. This mutation leads to abnormal signaling in cell growth and division, promoting tumor development. Testing for the BRAF V600 mutation is crucial for guiding treatment decisions, as targeted therapies, like BRAF inhibitors, can be effective for patients with this mutation. Identifying the presence of the mutation helps oncologists tailor personalized treatment plans, improving outcomes for patients with BRAF-mutated tumors.

QuantiFERON TB Gold is a blood test used to diagnose latent tuberculosis (TB) infection. It measures the immune response to specific TB proteins, helping to determine if someone has been exposed to the bacteria that cause TB. Unlike traditional skin tests, QuantiFERON TB Gold is more specific and does not require a follow-up appointment for reading. It is particularly useful in populations with a low risk of false positives, such as those who have had the BCG vaccine. The test provides timely and reliable results, aiding in the early identification and management of TB infection.